Workflow
Silicon Laboratories(SLAB)
icon
Search documents
Silicon Laboratories (SLAB) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research· 2024-02-07 14:21
Silicon Laboratories (SLAB) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $1.44. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 17.36%. A quarter ago, it was expected that this chipmaker would post earnings of $0.61 per share when it actually produced earnings of $0.62, delivering a surprise of 1.64%.Over the last four quarters, the compan ...
Silicon Labs and Arduino Partner to Democratize Matter
Prnewswire· 2024-02-06 15:00
"Arduino's simplicity, ease of use, and powerful development environment is what makes them so appealing to their community of over 33 million users, whether they be Makers just getting started, or Pros with a wealth of development experience," said Rob Shane, Vice President of Mass Market Sales and Applications at Silicon Labs. "By combining Arduino's software libraries with Silicon Labs-based hardware, developers get the best of both worlds with our leading security, energy efficiency, and processing powe ...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Silicon Laboratories, Inc.
Businesswire· 2024-02-01 22:22
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Silicon Laboratories Inc. (“Silicon Labs” or the “Company”) (NASDAQ: SLAB). The investigation concerns whether Silicon Labs and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here for more information about the investigation] On January 29, 2024, Silicon Labs issued a press release “ announc[ing] a one-week delay to its s ...
Investigation Into Silicon Laboratories Inc. (SLAB) Announced by Holzer & Holzer, LLC
Newsfilter· 2024-02-01 22:03
ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Silicon Laboratories Inc. ("Silicon Labs" or the "Company") (NASDAQ:SLAB) complied with federal securities laws. On January 29, 2024, the Company postponed its scheduled earnings conference call, disclosing that it "determined that a material weakness in internal control related to the operation and documentation of certain inventory controls existed as of December 30, 2023. The delay in reporting allows additional time ...
Silicon Laboratories Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Newsfilter· 2024-01-30 16:14
BOSTON, Jan. 30, 2024 (GLOBE NEWSWIRE) --  Block & Leviton is investigating Silicon Laboratories, Inc. (NASDAQ:SLAB) for potential securities law violations. Investors who have lost money in their Silicon Laboratories, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/slab. What is this all about? On January 30, 2024 Silicon Laboratories announced that the Company was delaying its scheduled earnings cal ...
Silicon Labs Delays Q4 2023 Earnings Conference Call
Prnewswire· 2024-01-29 22:09
The company is assessing the documentation of controls related to inventoryAUSTIN, Texas, Jan. 29, 2024 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced a one-week delay to its scheduled earnings conference call for the quarter ended on December 30, 2023. The company has determined that a material weakness in internal control related to the operation and documentation of certain inventory controls existed as of Decem ...
Silicon Labs Announces Fourth Quarter 2023 Earnings Webcast
Prnewswire· 2024-01-17 13:05
AUSTIN, Texas, Jan. 17, 2024 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced that it plans to release fourth quarter 2023 financial results on Wednesday, January 31, 2024. An earnings conference call will follow the release at 7:30 a.m. Central Time. The call will be streamed from the Investor Relations section of the company's website at silabs.com. A replay will be available after the call on the investor page of ...
Silicon Laboratories(SLAB) - 2023 Q3 - Earnings Call Transcript
2023-11-01 16:32
Financial Data and Key Metrics Changes - On a GAAP basis, gross margin ended at 58.4% with GAAP operating expenses at $107 million, which was $13 million below the midpoint of guidance due to changes in stock compensation expense [1] - Third quarter revenue was $204 million, down 24% year-on-year, with non-GAAP gross margin slightly lower than expected at 58.5% [7][8] - Non-GAAP operating expenses were $95 million, in line with expectations, and the company expects non-GAAP operating expenses in Q4 to be approximately $94 million [8][10] Business Line Data and Key Metrics Changes - The Industrial & Commercial business ended at $121 million, down 17% year-over-year, while Home & Life revenue was $83 million, down 33% year-over-year but up 4% sequentially [43] - Revenue was down year-over-year in both business units during the quarter [7] Market Data and Key Metrics Changes - Year-over-year decreases were observed in all regions, with APAC being down less than Europe and the Americas [17] - Distribution revenue was 81% for the third quarter, up slightly from the second quarter, with inventory in the channel around 90 days [17] Company Strategy and Development Direction - The company announced its next-generation platform called Series 3, which is expected to enhance its market position [6] - The company is focusing on long-term growth markets such as smart cities and healthcare, with significant deployments expected in the coming years [21][22] - The Series 3 platform is designed to support more than 100 times the processing capability of the current generation, including integrated AI and machine learning accelerators [49] Management's Comments on Operating Environment and Future Outlook - The current market environment is characterized by weak demand and high inventory levels, with end customers carrying excess inventory [5][19] - Management believes Q4 will be the bottom, with expectations for sequential growth in Q1 2024 [24] - The company is committed to managing operating expenses while maintaining investments in essential R&D projects [42] Other Important Information - The company repurchased approximately $16 million worth of shares in Q3, targeting around 100,000 shares [45] - The balance sheet remains healthy with cash and investments totaling $417 million [18] Q&A Session Summary Question: Concerns about design wins and revenue outlook - Management acknowledged concerns about the potential decrease in volumes and revenue underpinning design wins, attributing current challenges to inventory corrections rather than a permanent reduction in total addressable market (TAM) [27][28] Question: Inventory correction and guidance for Q4 - Management clarified that while they expect to clear a significant portion of inventory in Q4, some inventory issues may extend into Q1 2024 [32][34] Question: Flexibility of buyback program - Management confirmed flexibility in the buyback program, emphasizing a cautious approach to liquidity and market conditions [38][63] Question: Impact of inventory on revenue guidance - Management indicated that the inventory situation is complex, with varying levels of excess inventory across customers, impacting revenue guidance for Q4 [60][66] Question: OpEx budget for next year - Management expects OpEx in Q1 to be roughly flat compared to the second half of 2023, with ongoing monitoring based on market recovery [74]
Silicon Laboratories(SLAB) - 2023 Q3 - Quarterly Report
2023-10-31 16:00
Part I. Financial Information This section provides the unaudited condensed consolidated financial statements and management's discussion and analysis of financial condition and results of operations [Item 1. Financial Statements](index=5&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited condensed consolidated financial statements, including balance sheets, income statements, comprehensive income, changes in equity, and cash flows, along with detailed notes on significant accounting policies and other financial disclosures [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) This statement provides a snapshot of the Company's assets, liabilities, and stockholders' equity at specific points in time Metric (in thousands) | Metric (in thousands) | Sep 30, 2023 | Dec 31, 2022 | Change | % Change | | :-------------------- | :----------- | :----------- | :----- | :------- | | Cash and cash equivalents | $159,928 | $499,915 | $(339,987) | -68.0% | | Short-term investments | $257,157 | $692,024 | $(434,867) | -62.8% | | Accounts receivable, net | $102,142 | $71,437 | $30,705 | 43.0% | | Inventories | $167,581 | $100,417 | $67,164 | 66.9% | | Total current assets | $773,535 | $1,461,363 | $(687,828) | -47.1% | | Total assets | $1,475,062 | $2,169,428 | $(694,366) | -32.0% | | Accounts payable | $48,086 | $89,860 | $(41,774) | -46.5% | | Revolving line of credit | $45,000 | — | $45,000 | N/A | | Convertible debt, net | — | $529,573 | $(529,573) | -100.0% | | Total liabilities | $215,140 | $764,420 | $(549,280) | -71.9% | | Total stockholders' equity | $1,259,922 | $1,405,008 | $(145,086) | -10.3% | [Condensed Consolidated Statements of Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) This statement details the Company's revenues, expenses, and net income over specific reporting periods Metric (in thousands) | Metric (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Change (3M) | % Change (3M) | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | Change (9M) | % Change (9M) | | :-------------------- | :------------------------------ | :----------------------------- | :---------- | :------------ | :----------------------------- | :---------------------------- | :---------- | :------------ | | Revenues | $203,760 | $269,817 | $(66,057) | -24.5% | $695,413 | $766,781 | $(71,368) | -9.3% | | Gross profit | $119,025 | $165,585 | $(46,560) | -28.1% | $416,660 | $485,260 | $(68,600) | -14.1% | | Operating income | $12,217 | $30,223 | $(18,006) | -59.6% | $48,957 | $95,185 | $(46,228) | -48.6% | | Net income | $10,348 | $20,999 | $(10,651) | -50.7% | $35,271 | $66,041 | $(30,770) | -46.6% | | Basic EPS | $0.33 | $0.62 | $(0.29) | -46.8% | $1.11 | $1.84 | $(0.73) | -39.7% | | Diluted EPS | $0.32 | $0.60 | $(0.28) | -46.7% | $1.07 | $1.79 | $(0.72) | -40.2% | [Condensed Consolidated Statements of Comprehensive Income](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) This statement presents net income and other comprehensive income items, reflecting changes in equity from non-owner sources Metric (in thousands) | Metric (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Change (3M) | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | Change (9M) | | :-------------------- | :------------------------------ | :----------------------------- | :---------- | :----------------------------- | :---------------------------- | :---------- | | Net income | $10,348 | $20,999 | $(10,651) | $35,271 | $66,041 | $(30,770) | | Other comprehensive income (loss) | $1,491 | $(2,412) | $3,903 | $8,089 | $(14,048) | $22,137 | | Comprehensive income | $11,839 | $18,587 | $(6,748) | $43,360 | $51,993 | $(8,633) | [Condensed Consolidated Statements of Changes in Stockholders' Equity](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Changes%20in%20Stockholders'%20Equity) This statement outlines the changes in the Company's stockholders' equity over specific reporting periods Metric (in thousands) | Metric (in thousands) | Balance as of Dec 31, 2022 | Net income (9M 2023) | Other comprehensive income (9M 2023) | Stock issuances, net (9M 2023) | Repurchases of common stock (9M 2023) | Stock-based compensation (9M 2023) | Convertible debt activity (9M 2023) | Balance as of Sep 30, 2023 | | :-------------------- | :------------------------- | :------------------- | :----------------------------------- | :----------------------------- | :------------------------------------ | :--------------------------------- | :---------------------------------- | :------------------------- | | Total Stockholders' Equity | $1,405,008 | $35,271 | $8,089 | $(9,112) | $(213,130) | $37,360 | $(3,564) | $1,259,922 | [Condensed Consolidated Statements of Cash Flows](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) This statement reports the cash generated and used by the Company across operating, investing, and financing activities Metric (in thousands) | Metric (in thousands) | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | Change | | :-------------------- | :----------------------------- | :---------------------------- | :----- | | Net cash provided by (used in) operating activities | $(48,885) | $127,416 | $(176,301) | | Net cash provided by investing activities | $426,418 | $40,787 | $385,631 | | Net cash used in financing activities | $(717,520) | $(690,082) | $(27,438) | | Decrease in cash and cash equivalents | $(339,987) | $(591,346) | $251,359 | | Cash and cash equivalents at end of period | $159,928 | $483,277 | $(323,349) | [Notes to Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) This section provides detailed explanations and disclosures supporting the condensed consolidated financial statements [1. Significant Accounting Policies](index=10&type=section&id=1.%20Significant%20Accounting%20Policies) This note describes the key accounting principles and methods used in preparing the financial statements - The unaudited Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP for interim financial information and Form 10-Q instructions, with fiscal 2023 and 2022 both having 52 weeks[22](index=22&type=chunk)[24](index=24&type=chunk) - Revenue is recognized when control of promised goods or services is transferred to the customer, typically upon delivery of mixed-signal IC products, with variable consideration estimated and deferred if it does not meet recognition criteria[26](index=26&type=chunk)[27](index=27&type=chunk) [2. Earnings Per Share](index=12&type=section&id=2.%20Earnings%20Per%20Share) This note details the calculation of basic and diluted earnings per share for the Company Metric (in thousands, except per share data) | Metric (in thousands, except per share data) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :------------------------------------------- | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Net income | $10,348 | $20,999 | $35,271 | $66,041 | | Shares used in computing basic EPS | 31,796 | 34,079 | 31,789 | 35,935 | | Effect of dilutive securities | 282 | 700 | 1,130 | 1,033 | | Shares used in computing diluted EPS | 32,078 | 34,779 | 32,919 | 36,968 | | Basic EPS | $0.33 | $0.62 | $1.11 | $1.84 | | Diluted EPS | $0.32 | $0.60 | $1.07 | $1.79 | - The Company settled its 0.625% convertible senior notes due 2025 in June 2023, paying **$535.0 million** in cash and issuing **0.9 million** shares of common stock[28](index=28&type=chunk) [3. Fair Value of Financial Instruments](index=12&type=section&id=3.%20Fair%20Value%20of%20Financial%20Instruments) This note provides information on the fair value measurements of the Company's financial assets and liabilities Description (in thousands) | Description (in thousands) | Fair Value at Sep 30, 2023 (Level 1) | Fair Value at Sep 30, 2023 (Level 2) | Total Fair Value at Sep 30, 2023 | | :------------------------- | :----------------------------------- | :----------------------------------- | :------------------------------- | | Money market funds | $57,144 | — | $57,144 | | Corporate debt securities | — | $166,868 | $166,868 | | Government debt securities | — | $90,289 | $90,289 | | Total | $57,144 | $257,157 | $314,301 | Description (in thousands) | Description (in thousands) | Fair Value at Dec 31, 2022 (Level 1) | Fair Value at Dec 31, 2022 (Level 2) | Total Fair Value at Dec 31, 2022 | | :------------------------- | :----------------------------------- | :----------------------------------- | :------------------------------- | | Money market funds | $310,969 | — | $310,969 | | Corporate debt securities | — | $501,014 | $501,014 | | Government debt securities | — | $191,010 | $191,010 | | Total | $310,969 | $695,273 | $1,006,242 | - The fair value of the 2025 Notes was **$671.9 million** as of December 31, 2022, but no notes were outstanding as of September 30, 2023, following their conversion or redemption in June 2023[38](index=38&type=chunk) [4. Derivative Financial Instruments](index=15&type=section&id=4.%20Derivative%20Financial%20Instruments) This note describes the Company's use of derivative instruments to manage financial risks - The Company uses foreign currency forward contracts to manage exposure to foreign currency exchange rate variability, both as cash flow hedges for operating expenses (Norwegian Krone) and non-designated hedges for balance sheet exposures (Euro)[40](index=40&type=chunk)[41](index=41&type=chunk)[43](index=43&type=chunk) - As of September 30, 2023, cash flow hedges had an aggregate notional value of **$2.0 million** with maturities of one to three months, while non-designated hedges had an aggregate notional value of **$7.4 million**[42](index=42&type=chunk)[44](index=44&type=chunk) [5. Supplemental Information](index=17&type=section&id=5.%20Supplemental%20Information) This note provides additional details on specific financial statement line items, including inventories and lease income Inventories (in thousands) | Inventories (in thousands) | Sep 30, 2023 | Dec 31, 2022 | | :------------------------- | :----------- | :----------- | | Work in progress | $150,248 | $75,112 | | Finished goods | $17,333 | $25,305 | | Total | $167,581 | $100,417 | - Lease income from operating leases was **$2.3 million** for the nine months ended September 30, 2023, a decrease from **$5.4 million** in the prior year period[47](index=47&type=chunk) [6. Debt](index=17&type=section&id=6.%20Debt) This note outlines the Company's debt obligations, including convertible notes and revolving credit facilities - The Company redeemed and converted its **$535 million** principal amount 0.625% Convertible Senior Notes due 2025 in June 2023, paying **$533.6 million** in cash and issuing **0.9 million** shares of common stock for conversions, and redeeming the remaining **$1.4 million** at par[48](index=48&type=chunk)[49](index=49&type=chunk) Interest Expense (in thousands) | Interest Expense (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Contractual interest expense | $— | $826 | $1,493 | $2,511 | | Amortization of debt issuance costs | $— | $498 | $960 | $1,492 | | Total | $— | $1,324 | $2,453 | $4,003 | - As of September 30, 2023, the Company had a **$400 million** revolving credit facility with **$45.0 million** outstanding, and was in compliance with all covenants[51](index=51&type=chunk)[53](index=53&type=chunk) [7. Commitments and Contingencies](index=18&type=section&id=7.%20Commitments%20and%20Contingencies) This note discloses the Company's legal proceedings, commitments, and potential contingent liabilities - The Company is involved in various legal proceedings in the normal course of business, but does not expect them to have a material adverse effect on its financial statements[54](index=54&type=chunk) [8. Revenues](index=19&type=section&id=8.%20Revenues) This note provides a breakdown of the Company's revenues by product category and sales channel Revenue by Product Category (in thousands) | Revenue by Product Category (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :----------------------------------------- | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Industrial & Commercial | $120,957 | $145,661 | $436,973 | $416,475 | | Home & Life | $82,803 | $124,156 | $258,440 | $350,306 | | Total | $203,760 | $269,817 | $695,413 | $766,781 | Revenue by Sales Channel (in thousands) | Revenue by Sales Channel (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :-------------------------------------- | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Distributors | $164,444 | $217,355 | $556,963 | $621,563 | | Direct customers | $39,316 | $52,462 | $138,450 | $145,218 | | Total | $203,760 | $269,817 | $695,413 | $766,781 | [9. Stock-Based Compensation](index=19&type=section&id=9.%20Stock-Based%20Compensation) This note details the accounting for stock-based compensation expenses recognized by the Company Stock-Based Compensation Costs (in thousands) | Stock-Based Compensation Costs (in thousands) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :-------------------------------------------- | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Cost of revenues | $192 | $288 | $774 | $834 | | Research and development | $8,598 | $8,788 | $26,903 | $23,482 | | Selling, general and administrative | $(3,000) | $6,874 | $9,490 | $18,897 | | Total | $5,790 | $15,950 | $37,167 | $43,213 | - For the three months ended September 30, 2023, the Company recognized an expense reversal of **$9.5 million** due to a reduction in estimated achievement levels for unvested performance stock units[58](index=58&type=chunk) - As of September 30, 2023, total unrecognized compensation cost related to equity grants was approximately **$103.8 million**, expected to be recognized over a weighted-average period of **2.2 years**[59](index=59&type=chunk) [10. Income Taxes](index=21&type=section&id=10.%20Income%20Taxes) This note explains the Company's income tax provision, effective tax rate, and unrecognized tax benefits Income Tax Metric (in millions) | Income Tax Metric (in millions) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :------------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Provision for income taxes | $3.4 | $14.2 | $23.5 | $36.9 | | Effective tax rate | 24.7% | 40.3% | 40.0% | 35.8% | - The decrease in the effective tax rate for the three months ended September 30, 2023, was primarily due to decreased nondeductible stock compensation and a delay in foreign tax credit regulations, partially offset by increased impact of global intangible low-taxed income[61](index=61&type=chunk)[103](index=103&type=chunk) - The Company had gross unrecognized tax benefits of **$5.2 million** as of September 30, 2023, and is appealing a Norwegian Tax Administration assessment for 2013 taxable income, which could result in **$13.2 million** additional tax[62](index=62&type=chunk)[63](index=63&type=chunk) [11. Subsequent Event](index=21&type=section&id=11.%20Subsequent%20Event) This note discloses significant events that occurred after the balance sheet date but before the financial statements were issued - The Company expects to incur approximately **$6.5 million** in restructuring-related expenses, primarily severance charges from a reduction-in-force, in the fourth quarter of fiscal year 2023[67](index=67&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=23&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on the Company's financial condition and operational results, including macroeconomic impacts, business overview, highlights, and liquidity [Impact of Macroeconomic Conditions](index=23&type=section&id=Impact%20of%20Macroeconomic%20Conditions) This section discusses how broader economic factors influence the Company's financial performance and market demand - The Company experienced a decline in revenues in Q3 2023 and expects a continued decline into Q4 due to customers slowing purchases to reduce existing inventories in a softening market, influenced by inflationary pressure, rising interest rates, and geopolitical tension[70](index=70&type=chunk) [Overview](index=23&type=section&id=Overview) This section provides a general description of the Company's business, products, and market focus - Silicon Laboratories Inc. is a fabless semiconductor company specializing in secure, intelligent wireless technology for IoT applications, including connected home, industrial automation, smart metering, and medical instrumentation, with products grouped into Industrial & Commercial or Home & Life categories[71](index=71&type=chunk)[72](index=72&type=chunk) - The sales cycle for ICs can be **12 months or more**, with an additional **3-6 months** for significant volume shipments, leading to potential delays between incurring R&D/SG&A expenses and corresponding sales[73](index=73&type=chunk) [Current Period Highlights](index=24&type=section&id=Current%20Period%20Highlights) This section summarizes key financial and operational achievements and challenges during the reporting period - Revenues decreased by **$66.1 million** in Q3 2023 compared to Q3 2022, driven by declines in both Home & Life and Industrial & Commercial products, with gross profit decreasing by **$46.6 million** and gross margin falling to **58.4%** from **61.4%**[75](index=75&type=chunk) - Operating expenses decreased by **$28.6 million** in Q3 2023 due to cost containment measures (e.g., bonus elimination, reduced contract employees, travel suspension) and lower stock-based compensation[75](index=75&type=chunk) - The Company ended Q3 2023 with **$417.1 million** in cash, cash equivalents, and short-term investments, with net cash used in operating activities of **$48.9 million** for the nine-month period, while accounts receivable (DSO) increased to **45 days** and inventory (DOI) increased to **178 days**[76](index=76&type=chunk)[108](index=108&type=chunk)[109](index=109&type=chunk)[110](index=110&type=chunk)[111](index=111&type=chunk) - The Company introduced new dual-band SoCs and integrated Bluetooth® SoC and MCU families in the first nine months of fiscal 2023 to expand its product portfolio[77](index=77&type=chunk) [Results of Operations](index=24&type=section&id=Results%20of%20Operations) This section provides a detailed analysis of the Company's revenues, expenses, and profitability trends Metric (as % of revenues) | Metric (as % of revenues) | Three Months Ended Sep 30, 2023 | Three Months Ended Oct 1, 2022 | Nine Months Ended Sep 30, 2023 | Nine Months Ended Oct 1, 2022 | | :------------------------ | :------------------------------ | :----------------------------- | :----------------------------- | :---------------------------- | | Revenues | 100.0% | 100.0% | 100.0% | 100.0% | | Cost of revenues | 41.6% | 38.6% | 40.1% | 36.7% | | Gross margin | 58.4% | 61.4% | 59.9% | 63.3% | | Research and development | 38.8% | 31.4% | 36.6% | 32.0% | | Selling, general and administrative | 13.6% | 18.8% | 16.3% | 18.8% | | Operating income | 6.0% | 11.2% | 7.0% | 12.4% | | Net income | 5.1% | 7.8% | 5.1% | 8.6% | - Revenue decreased by **24.5%** in the three-month period and **9.3%** in the nine-month period, primarily due to decreased Home & Life product revenues and overall weaker demand, with customers reducing inventory and requesting cancellations/price concessions[89](index=89&type=chunk)[91](index=91&type=chunk)[92](index=92&type=chunk) - Gross profit decreased due to lower unit volumes and variations in product mix, leading to a **3.0%** (3M) and **3.4%** (9M) decline in gross margin[93](index=93&type=chunk) - R&D expense decreased by **$5.6 million (6.6%)** in the three-month period due to lower personnel-related expenses (bonuses/variable compensation), but increased by **$8.6 million (3.5%)** in the nine-month period due to higher salary, stock compensation, and IT costs[95](index=95&type=chunk)[96](index=96&type=chunk) - SG&A expense decreased by **$22.9 million (45.3%)** in the three-month period and **$31.0 million (21.5%)** in the nine-month period, mainly due to reduced personnel-related costs (stock compensation, bonuses/variable compensation) and lower outside services[99](index=99&type=chunk)[100](index=100&type=chunk) - Interest income and other, net decreased in the three-month period due to lower interest-bearing investment balances but increased in the nine-month period due to higher market interest rates[101](index=101&type=chunk) [Business Outlook](index=32&type=section&id=Business%20Outlook) This section presents management's expectations for future financial performance and market conditions Income Statement Item | Income Statement Item | Q4 2023 Estimate | | :-------------------- | :--------------- | | Revenues | $70 million to $100 million | | Gross margin | 53% | | Operating expenses | $123 million | | Diluted earnings (loss) per share | $(2.39) to $(1.95) | [Liquidity and Capital Resources](index=32&type=section&id=Liquidity%20and%20Capital%20Resources) This section assesses the Company's ability to generate and manage cash, fund operations, and meet financial obligations - As of September 30, 2023, the Company had **$417.1 million** in cash, cash equivalents, and short-term investments, with **$268.6 million** held by U.S. entities[108](index=108&type=chunk) - Net cash used in operating activities was **$48.9 million** for the nine months ended September 30, 2023, a significant decrease from **$127.4 million** provided in the prior year, primarily due to changes in operating assets and liabilities[109](index=109&type=chunk) - Accounts receivable increased to **$102.1 million (45 DSO)** from **$71.4 million (25 DSO)** at December 31, 2022, partly due to extended payment terms offered to customers, while inventory increased to **$167.6 million (178 DOI)** from **$100.4 million (90 DOI)** to minimize supply disruptions and meet forecasted demand[110](index=110&type=chunk)[111](index=111&type=chunk) - Net cash provided by investing activities increased to **$426.4 million** (9M 2023) from **$40.8 million** (9M 2022), mainly due to net purchases, sales, and maturities of marketable securities[112](index=112&type=chunk) - Net cash used in financing activities was **$717.5 million** (9M 2023), primarily due to **$571.2 million** in debt payments (convertible notes) offset by decreased stock repurchases and proceeds from the revolving credit facility[113](index=113&type=chunk) - The Company believes existing liquidity sources are sufficient for short-term and long-term capital requirements, but may seek additional funding for acquisitions or other reasons[116](index=116&type=chunk) [Critical Accounting Estimates](index=33&type=section&id=Critical%20Accounting%20Estimates) This section discusses accounting estimates that require significant judgment and could materially impact financial results - There have been no material changes to the Company's critical accounting estimates since the fiscal year ended December 31, 2022, as described in its Form 10-K[117](index=117&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=33&type=section&id=Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) This section provides insights into the Company's exposure to market risks, including interest rate and foreign currency fluctuations - A **100 basis point** decline in yield on the investment portfolio would decrease annual interest income by approximately **$3.2 million**[118](index=118&type=chunk) - A **100 basis point** increase in interest rates would increase annual interest expense by approximately **$0.5 million**, based on the **$45.0 million** outstanding on the credit facility[119](index=119&type=chunk) - The Company is exposed to foreign currency exchange rate risk, primarily through foreign subsidiaries' assets, liabilities, and operating expenses denominated in non-U.S. dollar currencies, and uses foreign currency forward contracts to manage this exposure[120](index=120&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=35&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section incorporates by reference the market risk disclosures from management's discussion and analysis - Information related to quantitative and qualitative disclosures regarding market risk is incorporated by reference from Item 2[122](index=122&type=chunk) [Item 4. Controls and Procedures](index=35&type=section&id=Item%204.%20Controls%20and%20Procedures) This section details the evaluation of the Company's disclosure controls and procedures and reports on internal control changes - Management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of September 30, 2023, providing reasonable assurance that required information is recorded, processed, summarized, and reported timely[123](index=123&type=chunk) - There were no material changes in internal controls over financial reporting during the fiscal quarter ended September 30, 2023[124](index=124&type=chunk) Part II. Other Information This section provides additional information not covered in the financial statements, including legal proceedings, risk factors, and equity sales [Item 1. Legal Proceedings](index=35&type=section&id=Item%201.%20Legal%20Proceedings) This section refers to the notes to financial statements for information regarding ongoing legal matters - Information regarding legal proceedings is provided in Note 7, Commitments and Contingencies, to the Condensed Consolidated Financial Statements and is incorporated by reference[125](index=125&type=chunk) [Item 1A. Risk Factors](index=36&type=section&id=Item%201A.%20Risk%20Factors) This section outlines various risks that could materially and adversely affect the Company's business, financial condition, and results of operations [Global Business Risks](index=36&type=section&id=Global%20Business%20Risks) This section details risks related to supply chain, industry cyclicality, international operations, competition, and product development - The Company relies on third-party vendors for manufacturing, assembly, and testing, exposing it to supply chain disruptions, capacity constraints, and geopolitical risks, particularly concerning Taiwan Semiconductor Manufacturing Co. (TSMC) and Semiconductor Manufacturing International Corporation (SMIC) in Asia[126](index=126&type=chunk)[127](index=127&type=chunk)[128](index=128&type=chunk)[130](index=130&type=chunk) - The semiconductor industry is highly cyclical, characterized by rapid technological change, product obsolescence, and price erosion, leading to significant fluctuations in product supply and demand, with current macroeconomic conditions contributing to a downturn[133](index=133&type=chunk)[134](index=134&type=chunk) - International operations, which accounted for **87%** of revenues in the nine months ended September 30, 2023, are subject to risks like trade restrictions, geopolitical tensions (e.g., China-Taiwan relations), and currency fluctuations[136](index=136&type=chunk)[138](index=138&type=chunk) - Concentration of manufacturers, assemblers, test service providers, distributors, and customers in the Pacific Rim region increases vulnerability to natural disasters, epidemics (like COVID-19), political unrest, and labor strikes[139](index=139&type=chunk)[140](index=140&type=chunk) - The Company faces intense competition from larger competitors with greater resources, potentially leading to aggressive pricing, reduced sales, and lower gross profit[141](index=141&type=chunk)[144](index=144&type=chunk)[145](index=145&type=chunk) - Inability to manage growth, including expanding global operations and upgrading systems, could adversely affect the business, while cybersecurity threats and IT failures pose risks to operations, reputation, and financial condition[146](index=146&type=chunk)[147](index=147&type=chunk)[151](index=151&type=chunk) - Operating results may fluctuate significantly due to factors like order timing, new product introductions, market acceptance, supplier capacity, and product mix, leading to stock price volatility[153](index=153&type=chunk)[154](index=154&type=chunk)[157](index=157&type=chunk) - Future success depends on timely development and market acceptance of new products and technologies, with substantial R&D investment (**36.6%** of revenues for 9M 2023), and failure to anticipate new technologies or achieve market acceptance could harm competitive position[158](index=158&type=chunk)[160](index=160&type=chunk)[161](index=161&type=chunk) - Acquisitions and dispositions carry risks such as integration problems, diversion of management attention, financial resource needs, and potential loss of key employees or customer relationships[162](index=162&type=chunk)[164](index=164&type=chunk)[176](index=176&type=chunk) - Rapid decreases in average selling prices could negatively impact revenues and gross profit if not offset by increased sales volumes or reduced production costs[165](index=165&type=chunk) - Dependence on distributors (**80%** of 9M 2023 revenue) and lack of long-term customer commitments expose the Company to risks of channel management conflicts, price protection, inventory returns, and customer diversification efforts[166](index=166&type=chunk)[167](index=167&type=chunk)[168](index=168&type=chunk) - Building products based on customer forecasts before receiving purchase orders increases inventory risks, including high carrying costs and obsolescence, especially with indirect sales channels[168](index=168&type=chunk) - The COVID-19 pandemic and similar public health crises pose ongoing risks to business operations, supply chains, customer demand, and financial markets[169](index=169&type=chunk)[170](index=170&type=chunk) - Product complexity and potential errors, especially in wireless connectivity and IoT products, could lead to liability claims, increased costs, and reputational damage, with risks disproportionately higher than product revenues[171](index=171&type=chunk)[172](index=172&type=chunk)[173](index=173&type=chunk) - Lengthy and expensive customer qualification processes for products offer no assurance of sales, and delays can impede growth, while manufacturing process complexity can lead to lower yields, affecting product availability and gross profit[174](index=174&type=chunk)[178](index=178&type=chunk) - Reliance on customers to support products and potential competition from customer-developed products could diminish demand, while changes in privacy and data security laws (e.g., GDPR) increase operational costs and compliance risks[179](index=179&type=chunk)[180](index=180&type=chunk)[181](index=181&type=chunk) - Products must conform to evolving industry standards, particularly in the IoT market, and failure to comply or anticipate new standards could adversely affect market acceptance and competitive position[182](index=182&type=chunk)[183](index=183&type=chunk) [Intellectual Property Risks](index=58&type=section&id=Intellectual%20Property%20Risks) This section addresses risks associated with intellectual property litigation, protection, and third-party technology licensing - The semiconductor and software industries are prone to significant intellectual property litigation, which can be costly, time-consuming, and divert management attention, potentially leading to liabilities, invalidation of proprietary rights, or forced changes in product use/development[186](index=186&type=chunk)[187](index=187&type=chunk) - Inability to protect proprietary technology through patents, copyrights, trademarks, and trade secrets, especially in foreign countries, could negatively affect the ability to compete[188](index=188&type=chunk) - Incorporating third-party licensed technology in products exposes the Company to infringement claims and performance risks, with indemnification often limited[189](index=189&type=chunk) [Liquidity and Credit Risks](index=60&type=section&id=Liquidity%20and%20Credit%20Risks) This section covers risks related to financial market disruptions, accounts receivable, debt obligations, and capital availability - Disruptions in the financial services industry, such as bank closures, could impact the Company's access to cash, investments, or credit lines, and lead to less favorable financing terms[190](index=190&type=chunk) - The Company is exposed to credit risks related to accounts receivable, particularly from its ten largest customers/distributors, as it generally does not obtain letters of credit or other payment security[191](index=191&type=chunk) - Debt obligations, including the credit facility, are subject to financial covenants, and a breach could lead to immediate repayment demands, with the ability to service debt depending on future performance and economic conditions[192](index=192&type=chunk) - While current liquidity is believed sufficient, additional debt or equity capital may be needed for future activities or acquisitions, but availability and terms are uncertain, especially during financial market instability[193](index=193&type=chunk) [Stock and Governance Risks](index=60&type=section&id=Stock%20and%20Governance%20Risks) This section discusses risks concerning stock price volatility and corporate governance provisions that could affect control - The Company's stock price may be volatile due to fluctuations in operating results, analyst estimates, market valuations of technology companies, new product introductions, changes in market standards, and other factors[194](index=194&type=chunk)[197](index=197&type=chunk) - Provisions in the Company's charter documents and Delaware law, such as a classified Board of Directors and restrictions on stockholder actions, could prevent, delay, or impede a change in control and potentially reduce the market price of common stock[198](index=198&type=chunk)[200](index=200&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=62&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section summarizes the Company's common stock repurchases under its authorized share repurchase program Period | Period | Total Number of Shares Purchased (in thousands) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (in thousands) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) | | :--------------------------- | :---------------------------------------------- | :--------------------------- | :-------------------------------------------------------------------------------------------- | :---------------------------------------------------------------------------------------------------- | | July 2, 2023 – July 29, 2023 | 82 | $145.89 | 82 | $104,047 | | July 30, 2023 – August 26, 2023 | 27 | $148.58 | 27 | $100,000 | | August 27, 2023 – September 30, 2023 | — | — | — | $100,000 | | Total | 109 | $146.56 | 109 | | - The Company's share repurchase program authorizes repurchases up to **$600 million** through December 2023, allowing for open market or private transactions[199](index=199&type=chunk) [Item 3. Defaults Upon Senior Securities](index=63&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) This section confirms that there are no applicable defaults upon senior securities - Not applicable[201](index=201&type=chunk) [Item 4. Mine Safety Disclosures](index=63&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This section states that there are no applicable mine safety disclosures - Not applicable[201](index=201&type=chunk) [Item 5. Other Information](index=63&type=section&id=Item%205.%20Other%20Information) This section reports on Rule 10b5-1 trading arrangements by directors and officers - No Rule 10b5-1 trading arrangements were entered into or terminated by the Company's directors and officers during the quarter ended September 30, 2023[201](index=201&type=chunk) [Item 6. Exhibits](index=64&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed as part of the report, including agreements, certificates, bylaws, and certifications - The report includes various exhibits such as the Asset Purchase Agreement, Certificate of Incorporation, Bylaws, Credit Agreement, and certifications required by the Sarbanes-Oxley Act[203](index=203&type=chunk)
Silicon Laboratories(SLAB) - 2023 Q2 - Earnings Call Transcript
2023-07-26 16:24
Financial Data and Key Metrics Changes - The second quarter revenue was $245 million, down 7% year-over-year, but above the midpoint of guidance [113] - Non-GAAP earnings per share ended slightly above the midpoint of guidance at $1.04, primarily due to revenue upside and favorable operating expenses [114] - GAAP earnings per share were $0.33 for the quarter, slightly below guidance [5] - Non-GAAP gross margin ended lower than expected at 58.9% due to product mix [26] - GAAP operating expenses were $127 million, while non-GAAP operating expenses were $104 million [114][26] Business Line Data and Key Metrics Changes - The Industrial and Commercial business unit achieved $165 million in revenue, up 15% year-over-year [4] - The Home & Life business unit declined 33% year-over-year to $80 million, impacted by high levels of customer inventory [91] - The design win pipeline increased by 23% year-over-year in the first half of 2023, indicating strong momentum [3] Market Data and Key Metrics Changes - Europe showed the greatest strength in Q2, with revenue up 14% year-on-year, while revenue for APAC and the Americas was down year-on-year [91] - Days sales outstanding (DSO) remained stable at 79 days [91] - The largest customer accounted for less than 4% of revenue, with the top 10 customers representing about 24% of revenue [91] Company Strategy and Development Direction - The company is focused on disciplined execution and managing expenses without impacting long-term potential [29] - The Series 2 product portfolio is expected to capture market share, with strategic inventory being accumulated ahead of anticipated market recovery [29] - The company is preparing for the launch of the Series 3 platform, which represents a significant advancement in IoT technology [31] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing market headwinds and broad demand weakness, but expressed confidence in mid- and long-term revenue growth potential [90] - The company is experiencing low levels of bookings, impacting both business units, and expects revenue for Q3 to decline [93] - Management highlighted that the current environment is characterized by weak customer visibility and confidence, affecting ordering patterns [54] Other Important Information - The company ended the quarter with cash and investments of $506 million and a total inventory of $146 million [92] - The company executed a buyback of approximately $184 million, retiring around 1.3 million shares [27] - The company is participating in two upcoming conferences to enhance visibility and engagement with investors [98] Q&A Session Summary Question: What is the expected steady state sell-through for the Home and Life segment? - Management indicated that the Home and Life segment has been significantly impacted by customer inventory levels, and they expect a period of adjustment to clear this inventory [35][100] Question: Can you elaborate on the inventory position in Industrial and Commercial? - Management acknowledged that while Industrial and Commercial have shown resilience, they are also experiencing some inventory corrections, and the market environment remains challenging [108] Question: How is the company managing operating expenses in the current environment? - Management stated that recent reductions in operating expenses are primarily discretionary and temporary, with plans to revert these actions as market conditions improve [18] Question: What is the outlook for the Series 2 product ramp? - Management confirmed that the Series 2 ramp has already started and is expected to contribute significantly to revenue growth over the coming years [57] Question: How is the company addressing the impact of the new cybersecurity labeling initiative? - Management indicated that while the initiative is important, it will take time to see a significant impact on the top line, as such changes typically unfold gradually [74]